Our pricing services assist Biopharmaceutical companies in determining and optimizing their assets’ price using robust price elicitation techniques customized to the perceived assets’ value

• MKTXS has successfully advised manufacturers on strategies minimizing/limiting price erosion, such as indication launch sequencing, and tiered pricing in an increasingly complex and value-based pricing landscape
• Given recent trends, such as external price referencing, parallel trade, increasing generic/biosimilar threat, MKTXS has provided price-optimizing roadmaps for use in the global marketplace 
• Our pricing experts utilize various direct and indirect qualitative and quantitative methodologies to inform client price decision-making 
  • Van Westendorp (price sensitivity)
  • Brand-Price Trade-Off (BPTO)
  • Monadic Pricing
  • Competitor/analog price-value tradeoff

MKTXS collaborates with global financial stakeholders to gain pricing, and corresponding access recommendations at a global, regional and/or local level